Sodium Intake and Atopic Dermatitis
Clinical Summary
View sourceWhat was studied
A cross-sectional analysis of 215,832 UK Biobank adults (aged 37–73) examined whether higher estimated 24-hour urinary sodium (from a single spot urine collected 2006–2010 using a sex-specific equation) was associated with AD diagnoses and activity based on electronic medical record codes; findings were checked in a 13,014-participant NHANES validation cohort using dietary recall for sodium.
Key findings
Each 1 g/day higher estimated urinary sodium was associated with higher odds of AD (adjusted OR 1.11, 95% CI 1.07–1.14), active AD (1.16, 1.05–1.28), and increasing AD severity (1.11, 1.07–1.15); 10,839 of 215,832 participants (5.0%) had AD. In NHANES (n=13,014), each 1 g/day higher dietary sodium (recall) was associated with current AD (adjusted OR 1.22, 95% CI 1.01–1.47).
Study limitations
Cross-sectional design. Sodium exposure was estimated from a single spot urine sample via an equation rather than measured 24-hour collections; AD outcomes were defined from diagnostic and prescription codes.
Clinical implications
Higher estimated sodium intake was associated with greater odds of AD diagnosis, activity, and severity. Discuss sodium intake with patients as a low-risk consideration, while recognizing this study does not test whether reducing sodium improves AD.
Related Questions
Explore related topics and deepen your understanding